28 Mar 2017
From Big Pharma to the cannabis industry: Q&A with PharmaCann’s Chris DiorioBy Omar Sacirbey If marijuana business entrepreneurs are wondering whether pharmaceutical professionals might be interested in jumping over to cannabis, the answer is a resounding yes. Take Chris Diorio, a 25-year pharma industry veteran who recently made such a move, becoming director of research and development for PharmaCann of New York.
PharmaCann has a cultivation and processing site and four vertically integrated dispensaries in New York, as well two grow sites in Illinois, where the company is headquartered. Diorio’s path to PharmaCann started simply enough during a dinner with two former colleagues, one who previously worked with ... From Big Pharma to the cannabis industry: Q&A with PharmaCann’s Chris Diorio is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs